HR 1026 United States House · 117th Congress

LABEL Opioids Act

Summary
Lessening Addiction By Enhancing Labeling Opioids Act of 2021 or the LABEL Opioids Act This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose. A registrant (e.g., a pharmacist) who dispenses an opioid in violation of the labeling requirement is subject to penalties.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2021
Committee Review
Floor Vote
President
Introduced Feb 11, 2021 Last action Apr 28, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
3
Apr 28, 2021
Committee
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
lower
Feb 12, 2021
Committee
Referred to the Subcommittee on Health.
lower
Feb 11, 2021
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Feb 11, 2021
Introduced
Introduced in House
lower
1 primary · 8 co-sponsors

Sponsors